Organon & Co. · NYSE:OGN
Arjona Ferreira Juan Camilo exercised options for 11,519 Organon & Co. shares (Form 4)
Traded Aug 11, 2026 · Filed Aug 12, 2026
On Aug 11, 2026, Arjona Ferreira Juan Camilo (Head of R&D & CMO) exercised options for 11,519 Organon & Co. shares, leaving 37,432 shares. Filed Aug 12, 2026 (Form 4).
- Options exercised
- 11,519 shares
- Holding after
- 37,432 shares
- Trading plan
- No
- Role
- Head of R&D & CMO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Common Stock | Option exercise | 11,519 | 41,566 | Direct | |
| Aug 11, 2026 | Common Stock | Shares withheld for tax | 4,134 | US$13.62 | 37,432 | Direct |
Source
Related
- Organon & Co.
- Arjona Ferreira Juan Camilo
- Organon & Co. shareholders
- Form 4 · Arjona Ferreira Juan Camilo · Apr 2, 2026
- Schedule 13G · Pentwater Capital Management LP · Aug 14, 2026
- Form 4 · Drinane Juliana Papa · Aug 5, 2026
- Schedule 13G/A · Vanguard Portfolio Management LLC · Jul 31, 2026
- Form 4/A · Holzbaur Lynette · May 7, 2026
- Form 4 · Holzbaur Lynette · May 7, 2026